Alexion is a global biopharmaceutical company focused on serving patients with severe and rare disorders through the innovation, development and commercialization of life-transforming therapeutic products. Their goal is to deliver medical breakthroughs where none currently exist, and they are committed to ensuring that patient perspective and community engagement is always at the forefront of their work.
Every month SRNA holds a podcast on a topic that affects those with rare neuroimmune disorders. Experts in the field share the latest knowledge and answer questions from our community. Podcasts have covered topics such as vaccinations and rare neuroimmune disorders, rehabilitation, and clinical trials. The podcasts are available for download on iTunes.
This podcast series is sponsored in part by*
Amgen is focused on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. They apply scientific expertise and courage to bring clinically meaningful therapies to patients. Amgen believes science and compassion must work together to transform lives. For additional information about Amgen, please visit: amgen.com.
UCB innovates and delivers solutions that make real improvements for people living with severe diseases. We partner with and listen to patients, caregivers, and stakeholders across the healthcare system to identify promising innovations that create valuable health solutions.
* The Executive Committee of SRNA with the medical and scientific council determines the content and topics of the podcasts. Sponsors are not able to influence the education program.
